DE60132782D1 - Prodrugs zu nmda-rezeptorliganden - Google Patents

Prodrugs zu nmda-rezeptorliganden

Info

Publication number: DE60132782D1
Authority: DE; Germany
Prior art keywords: prodrugs; nmda receptor; receptor ligands; ligands; nmda
Prior art date: 2000-08-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60132782T

Other languages

English (en)

Other versions

DE60132782T2 (de

Inventor

Alexander Alanine

Bernd Buettelmann

Holger Fisher

Neidhart Marie-Paule Heitz

Joerg Huwyler

Georg Jaeschke

Emmanuel Pinard

Rene Wyler

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

F Hoffmann La Roche AG

Original Assignee

F Hoffmann La Roche AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-21

Filing date

2001-08-20

Publication date

2008-03-27

2001-08-20 Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG

2008-03-27 Publication of DE60132782D1 publication Critical patent/DE60132782D1/de

2009-02-05 Application granted granted Critical

2009-02-05 Publication of DE60132782T2 publication Critical patent/DE60132782T2/de

2021-08-21 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Molecular Biology (AREA)
Psychology (AREA)
Biochemistry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

DE60132782T 2000-08-21 2001-08-20 Prodrugs zu nmda-rezeptorliganden Expired - Lifetime DE60132782T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP00117918		2000-08-21
EP00117918		2000-08-21
PCT/EP2001/009561 WO2002016321A1 (de)	2000-08-21	2001-08-20	Prodrugs to nmda receptor ligands

Publications (2)

Publication Number	Publication Date
DE60132782D1 true DE60132782D1 (de)	2008-03-27
DE60132782T2 DE60132782T2 (de)	2009-02-05

Family

ID=8169594

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60132782T Expired - Lifetime DE60132782T2 (de)	2000-08-21	2001-08-20	Prodrugs zu nmda-rezeptorliganden

Country Status (35)

Country	Link
US (1)	US6407235B1 (de)
EP (1)	EP1313703B1 (de)
JP (1)	JP4162991B2 (de)
KR (1)	KR100589991B1 (de)
CN (1)	CN1227230C (de)
AR (1)	AR030373A1 (de)
AT (1)	ATE386022T1 (de)
AU (2)	AU2001285894B2 (de)
BR (1)	BR0113348A (de)
CA (1)	CA2419279C (de)
CY (1)	CY1107937T1 (de)
CZ (1)	CZ303319B6 (de)
DE (1)	DE60132782T2 (de)
DK (1)	DK1313703T3 (de)
EC (1)	ECSP034489A (de)
EG (1)	EG24293A (de)
ES (1)	ES2299508T3 (de)
HR (1)	HRP20030125B1 (de)
HU (1)	HU229802B1 (de)
IL (1)	IL154254A0 (de)
JO (1)	JO2289B1 (de)
MA (1)	MA26947A1 (de)
MX (1)	MXPA03001311A (de)
MY (1)	MY136065A (de)
NO (1)	NO324941B1 (de)
NZ (1)	NZ523990A (de)
PA (1)	PA8525601A1 (de)
PE (1)	PE20020291A1 (de)
PL (1)	PL204215B1 (de)
PT (1)	PT1313703E (de)
RS (1)	RS51467B (de)
RU (1)	RU2272027C2 (de)
SI (1)	SI1313703T1 (de)
WO (1)	WO2002016321A1 (de)
ZA (1)	ZA200300894B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001245891A1 (en) *	2000-03-21	2001-10-03	The Procter & Gamble Company	Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
US6713490B2 (en)	2002-04-26	2004-03-30	Pfizer, Inc.	3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
EP1963258A4 (de) *	2005-12-19	2011-06-29	Methylgene Inc	Histon-deacetylase-hemmer zur verstärkung der aktivität antifungaler wirkstoffe
CN101610996A (zh)	2006-12-19	2009-12-23	梅特希尔基因公司	组蛋白脱乙酰酶抑制剂及其前体药物
US8796330B2 (en) *	2006-12-19	2014-08-05	Methylgene Inc.	Inhibitors of histone deacetylase and prodrugs thereof
EP3564234B1 (de)	2013-11-05	2021-09-29	AstraZeneca AB	Nmda-antagonist-prodrugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1048247C (zh) *	1994-01-31	2000-01-12	美国辉瑞有限公司	神经保护的苯并二氢吡喃化合物
DE4410822A1 (de)	1994-03-24	1995-09-28	Schering Ag	Neue Piperidin-Derivate
TW340842B (en) *	1995-08-24	1998-09-21	Pfizer	Substituted benzylaminopiperidine compounds
TW498067B (en)	1996-07-19	2002-08-11	Hoffmann La Roche	4-hydroxy-piperidine derivatives
TWI254043B (en)	1999-06-08	2006-05-01	Hoffmann La Roche	Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor

2001
- 2001-08-16 PA PA20018525601A patent/PA8525601A1/es unknown
- 2001-08-16 US US09/931,431 patent/US6407235B1/en not_active Expired - Lifetime
- 2001-08-16 PE PE2001000820A patent/PE20020291A1/es not_active Application Discontinuation
- 2001-08-17 AR ARP010103939A patent/AR030373A1/es active IP Right Grant
- 2001-08-17 MY MYPI20013876A patent/MY136065A/en unknown
- 2001-08-19 JO JO2001136A patent/JO2289B1/en active
- 2001-08-20 ES ES01965201T patent/ES2299508T3/es not_active Expired - Lifetime
- 2001-08-20 HU HU0301548A patent/HU229802B1/hu not_active IP Right Cessation
- 2001-08-20 WO PCT/EP2001/009561 patent/WO2002016321A1/de not_active Ceased
- 2001-08-20 AT AT01965201T patent/ATE386022T1/de active
- 2001-08-20 MX MXPA03001311A patent/MXPA03001311A/es active IP Right Grant
- 2001-08-20 RS YUP-130/03A patent/RS51467B/sr unknown
- 2001-08-20 EP EP01965201A patent/EP1313703B1/de not_active Expired - Lifetime
- 2001-08-20 CA CA002419279A patent/CA2419279C/en not_active Expired - Fee Related
- 2001-08-20 PL PL361387A patent/PL204215B1/pl unknown
- 2001-08-20 IL IL15425401A patent/IL154254A0/xx not_active IP Right Cessation
- 2001-08-20 RU RU2003107572/04A patent/RU2272027C2/ru not_active IP Right Cessation
- 2001-08-20 NZ NZ523990A patent/NZ523990A/en not_active IP Right Cessation
- 2001-08-20 AU AU2001285894A patent/AU2001285894B2/en not_active Ceased
- 2001-08-20 EG EG20010906A patent/EG24293A/xx active
- 2001-08-20 SI SI200130812T patent/SI1313703T1/sl unknown
- 2001-08-20 JP JP2002521197A patent/JP4162991B2/ja not_active Expired - Fee Related
- 2001-08-20 BR BR0113348-9A patent/BR0113348A/pt not_active Application Discontinuation
- 2001-08-20 CZ CZ20030492A patent/CZ303319B6/cs not_active IP Right Cessation
- 2001-08-20 HR HR20030125A patent/HRP20030125B1/xx not_active IP Right Cessation
- 2001-08-20 DK DK01965201T patent/DK1313703T3/da active
- 2001-08-20 CN CNB01814361XA patent/CN1227230C/zh not_active Expired - Fee Related
- 2001-08-20 PT PT01965201T patent/PT1313703E/pt unknown
- 2001-08-20 DE DE60132782T patent/DE60132782T2/de not_active Expired - Lifetime
- 2001-08-20 KR KR1020037002485A patent/KR100589991B1/ko not_active Expired - Fee Related
- 2001-08-20 AU AU8589401A patent/AU8589401A/xx active Pending
2003
- 2003-01-31 ZA ZA200300894A patent/ZA200300894B/en unknown
- 2003-02-19 NO NO20030781A patent/NO324941B1/no not_active IP Right Cessation
- 2003-02-20 EC EC2003004489A patent/ECSP034489A/es unknown
- 2003-02-21 MA MA27052A patent/MA26947A1/fr unknown
2008
- 2008-05-08 CY CY20081100485T patent/CY1107937T1/el unknown

Also Published As

Publication number	Publication date
WO2002016321A1 (de)	2002-02-28
US20020040037A1 (en)	2002-04-04
JO2289B1 (en)	2005-09-12
BR0113348A (pt)	2003-07-08
YU13003A (sh)	2006-05-25
MA26947A1 (fr)	2004-12-20
HUP0301548A3 (en)	2010-03-29
RS51467B (sr)	2011-04-30
NO20030781D0 (no)	2003-02-19
HK1059083A1 (en)	2004-06-18
EG24293A (en)	2009-01-08
MY136065A (en)	2008-08-29
EP1313703A1 (de)	2003-05-28
DK1313703T3 (da)	2008-05-19
CN1447793A (zh)	2003-10-08
EP1313703B1 (de)	2008-02-13
KR20030022417A (ko)	2003-03-15
PL204215B1 (pl)	2009-12-31
ES2299508T3 (es)	2008-06-01
NO20030781L (no)	2003-02-19
PL361387A1 (en)	2004-10-04
CZ303319B6 (cs)	2012-08-01
AR030373A1 (es)	2003-08-20
CA2419279A1 (en)	2002-02-28
AU2001285894B2 (en)	2006-06-15
CY1107937T1 (el)	2013-09-04
HRP20030125A2 (en)	2005-02-28
MXPA03001311A (es)	2003-06-30
ZA200300894B (en)	2004-04-30
ATE386022T1 (de)	2008-03-15
HRP20030125B1 (en)	2011-07-31
KR100589991B1 (ko)	2006-06-15
NZ523990A (en)	2004-09-24
JP4162991B2 (ja)	2008-10-08
CN1227230C (zh)	2005-11-16
HUP0301548A2 (hu)	2003-08-28
US6407235B1 (en)	2002-06-18
SI1313703T1 (sl)	2008-06-30
CA2419279C (en)	2008-10-14
PA8525601A1 (es)	2002-04-25
CZ2003492A3 (cs)	2004-01-14
IL154254A0 (en)	2003-09-17
HU229802B1 (hu)	2014-07-28
RU2272027C2 (ru)	2006-03-20
PT1313703E (pt)	2008-03-25
JP2004506715A (ja)	2004-03-04
ECSP034489A (es)	2003-03-31
NO324941B1 (no)	2008-01-07
PE20020291A1 (es)	2002-04-17
DE60132782T2 (de)	2009-02-05
AU8589401A (en)	2002-03-04

Publication	Publication Date	Title
NO20023895L (no)	2002-10-16	Anilin-avledete ligander for thyroid-reseptoren
MA25403A1 (fr)	2002-04-01	Ligandes de recepteur de melanocortine
DK1277428T3 (da)	2006-01-09	Kaffemaskine beregnet for et befordringsmiddel
GB2371093B (en)	2004-12-01	Device for setting the gap dimension for a turbomachine
ATE337292T1 (de)	2006-09-15	Trans-n- 4-(4-hydroxyphenyl)cyclohexylö-3- phenylpropionamid als subtyp-selektiver nmda rezeptor antagonist
DK1068202T3 (da)	2009-03-16	1-(-heteroarylpropyl- eller -prop-2-enyl)-4benzylpipderidiner som NMDA-receptor-antagonister
FI20001294L (fi)	2001-12-01	Vastauksen laskuttaminen tietoliikennejärjestelmässä
IL157031A0 (en)	2004-02-08	Thyroid receptor ligands
DE69910997D1 (de)	2003-10-09	Azabzyclische 5ht1 rezeptor liganden
AU4439801A (en)	2001-10-23	Pyrazolo-triazine derivatives as ligands for gaba receptors
ID22369A (id)	1999-10-07	Gandaran untuk suatu lampu pelepasan
DE60132782D1 (de)	2008-03-27	Prodrugs zu nmda-rezeptorliganden
DE60137986D1 (de)	2009-04-30	Hebelapparat
NO20022720L (no)	2002-08-08	Bruddsikker ventilplate for en sleideventil
FR2812773B1 (fr)	2004-10-01	Console de support d'elements permettant de former un chemin de cable
DE50104526D1 (de)	2004-12-23	Bremseinrichtung für ein Fahrrad
LT2000015A (lt)	2001-02-26	Nesteroidiniai ligandai estrogeno receptoriui
FR2820625B1 (fr)	2003-09-26	Support a brochette (s)
EE00276U1 (et)	2001-10-15	Seade ühelindilise filtri valmistamiseks
ES1046343Y (es)	2001-06-01	Cazo perfeccionado para medida de productos.
IT1321069B1 (it)	2003-12-30	Struttura perfezionata per un freno a tamburo.
ITMI20000183V0 (it)	2000-03-24	Matrice componibile per macchine scodettatrici
FI4581U1 (fi)	2000-09-11	Koukun kannatin
FI4760U1 (fi)	2000-12-19	Kannatinväline
ITMO20000114A0 (it)	2000-05-25	Mezzi a tappo

Legal Events

Date	Code	Title	Description
2009-03-12	8364	No opposition during term of opposition